Neil Schneider, ASA, MAAA
Advertisement
Articles by Neil Schneider, ASA, MAAA
Advertisement
Latest Updated Articles
- Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
5
